Vyriad

0 followers

‌

Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.

Industries

Biotechnology

Headquarters

Rochester, United States

Employees

51-200

Links

Org chart

Stephen J. Russell

Co-Founder & CEO

Stephen J. Russell

Collapse

Kah-Whye Peng

CTO

Alice S. Bexon

Chief Medical Officer

Jim Hannon

CFO

Catherine Benson

Director of Legal

Dr Alice Bexon

Chief Medical Officer

Joel Dickson

Supply Chain Manager

Kirstin Garner

Human Resources Manager

Sheri Tran

Sr Director of Quality and Compliance

Shruthi Naik

VP Comparative Oncology

Heather Bakalyar

Senior Director Of Intellectual Property

Luke Russell, Ph.D

Director, Business Development and Strategic Alliances

Teams

Business Operations

5 members

Research and Development

5 members

Leadership Team

4 members

Quality Assurance and Compliance

3 members

Similar companies

Kura Oncology

18 followers

Adverum Biotech

8 followers

SpringWorks Therapeutics

5 followers

Owkin

4 followers

Summit Therapeutics

4 followers

Prime Medicine

3 followers

CytomX

3 followers

Celldex Therapeutics

2 followers

Viridian Therapeutics

2 followers

Modern Meadow

2 followers

Vividion Therapeutics

1 follower

Explore companies